Medical countermeasures for national security: A new government role in the pharmaceuticalization of society

Social Science and Medicine

Volumn 131, Issue , 2015, Pages 263-271

  Elbe, Stefan ^a   Roemer Mahler, Anne ^a   Long, Christopher ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Bioterrorism; Health security; Medical countermeasures; National security; Pandemic preparedness; Pharmaceuticalization

Indexed keywords

BIOTERRORISM; DRUG INDUSTRY; DRUG MISUSE; EUROPE; FINANCIAL MANAGEMENT; GOVERNMENT; GOVERNMENT REGULATION; HEALTH CARE PLANNING; HUMAN; MANAGEMENT; ORGANIZATION AND MANAGEMENT; PANDEMICS; PREVENTION AND CONTROL; TECHNOLOGY; TRENDS; UNITED STATES;

BIOTERRORISM; DRUG INDUSTRY; EUROPE; FINANCING, GOVERNMENT; GOVERNMENT PROGRAMS; GOVERNMENT REGULATION; HUMANS; PANDEMICS; POLICY MAKING; PRESCRIPTION DRUG OVERUSE; SECURITY MEASURES; STRATEGIC STOCKPILE; TECHNOLOGY TRANSFER; UNITED STATES;

EID: 84899664966     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2014.04.035     Document Type: Article

References (78)

1. Abraham J. Pharmaceuticalization of society in context: theoretical, empirical and health dimensions. Sociology 2010, 44(4):603-622.
2. Aebersold Paul FDA experience with medical countermeasures under the animal rule. Advances in Preventive Medicine 2012, 2012:1-11.
3. Baker Maureen Quality Assuring the NPFS.. and Further RCGP Reflections on Pandemic H1N1(2009): a Report on the NPFS and the H1N1 Swine Flu Outbreak for the Chief Medical Officer 2010, Personal Correspondence.
4. BARDA BARDA Strategic Plan: 2011-2016 2011, Retrieved March 20, 2013 from:. http://www.phe.gov/about/barda/Pages/2011barda-stratplan.aspx.
5. Berndt E.R., Glennerster R., Kremer M.R., Lee J., Levine R., Weizsäcker G., Williams H. Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness. Health Economics 2007, 16:491-511.
6. Brown T. "Vulnerability is universal": considering the place of "security" and "vulnerability" within contemporary global health discourse. Social Science & Medicine 2011, 72(3):319-326.
7. Brown T., Bell M. Imperial or postcolonial governance? Dissecting the genealogy of a global public health strategy. Social Science & Medicine 2008, 67(10):1571-1579.
8. Cabinet Office AStrong Britain in an Age of Uncertainty: the National Security Strategy 2010, Cabinet Office, London.
9. Cabinet Office The National Security Strategy of the United Kingdom: Security in an Interdependent World 2008, The Cabinet Office, London.
10. Carpenter Daniel Reputation and Power:Organizational Image and Pharmaceutical Regulation at the FDA 2010, Princeton UP, Princeton, N.J.
11. Chimerix. (2013). Press Release. 3 June. Retrieved April 1, 2014 from:. http://ir.chimerix.com/releasedetail.cfm?ReleaseID=768559.
12. Biomedicalization: Technoscience, Health and Illness in the U.S. 2010, Duke UP, Durham. A. Clarke, L. Mamo, J. Fosket, J. Fishman, J. Shim (Eds.).
13. Conrad Peter The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders 2007, Johns Hopkins UP, Baltimore.
14. Cooper Melinda Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era 2008, Washington UP, Seattle.
15. Davies Sara Securitizing infectious disease. International Affairs 2008, 84(2):295-313.
16. Davis Courtney, Abraham J. Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science 2012, Palgrave, Houndmills.
17. Dingwall R., Hoffman L.M., Staniland K. Introduction: why a sociology of pandemics?. Sociology of Health & Illness 2013, 35(2):167-173.
18. Dry S., Leach M. Epidemics: Science, Governance, and Social Justice 2010, Earthscan, London.
19. Dumit Joseph Drugs for Life: How Pharmaceutical Companies Define Our Health 2012, Duke UP, Durham, NC.
20. EC Commission Staff Working Document on Health Security in the European Union and Internationally 2009, 23 November.
21. Elbe Stefan Securing circulation pharmaceutically: antiviral stockpiling and pandemic preparedness in the European Union. Security Dialogue 2014.
22. Elbe Stefan Security and Global Health: Towards the Medicalization of Insecurity 2010, Polity, Cambridge.
23. Elbe Stefan Haggling over viruses: the downside risks of securitizing infectious disease. Health Policy and Planning 2010, 25(6):476-485.
24. Elbe Stefan Virus Alert: Security, Governmentality and the AIDS Pandemic 2009, Columbia UP, New York.
25. Elbe Stefan Should HIV/AIDS be securitized? The ethical dilemmas of linking HIV/AIDS and security. International Studies Quarterly 2006, 50(1):119-144.
26. Elbe Stefan Strategic Implications of HIV/AIDS 2003, Adelphi Paper No. 357. International Studies for Strategic Studies, Oxford UP, Oxford.
27. EMA Authorization Procedures. European Medicines Agency 2014, Retrived on March 6, 2014 from:. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/q_and_a/q_and_a_detail_000080.jsp.
28. Enemark Christian Is pandemic flu a security threat?. Survival 2009, 51(1):191-214.
29. European Commission Preparedness and Response 2012, Retrieved December 16, 2013 from:. http://ec.europa.eu/health/preparedness_response/policy/index_en.htm.
30. European Council Council Conclusions on Health Security 2008, 16 December.
31. EU Presidency Confirms Agreement on Strengthening Responses to Serious Cross-Border Health Threats 2013, Retrieved May 28, 2013 from:. http://www.eu2013)ie/news/news-items/20130516crossborderhealthupdateengonly/.
32. FDA New Drug and Biological Drug Products; evidence Needed to demonstrate Effectiveness of New Drugs When Human efficacy Studies Are Not Ethical or Feasible. Federal Register 2002, 67(105). Retrieved 9 December 2011 from:. http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=2002_register%26docid=fr31my02-6.pdf.
33. Figuié M. Global health risks and cosmopolitisation: from emergence to interference. Sociology of Health & Illness 2013, 35(2):227-240.
34. Franco Crystal, Sell Tara Federal Agency biodefense funding, Fy2011-Fy2012. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2011, 9(2):117-137.
35. Franz D.R., Zajtchuk R. Biological terrorism: understanding the threat, preparation, and medical response. Disease-a-month 2002, 48(8):493-564.
36. Gabe J. Pharmaceuticalization. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society 2014, 1804-1810.
37. Gaffney Alexander In first for animal rule pathway, FDA approves GSKs raxibacumab. Regulatory Focus 17 December 2012, Available at:, (accessed 04.07.13.). http://www.raps.org/focus-online/news/news-article-view/article/2649/in-first-for-animal-rule-pathway-fda-approves-gsks-raxibacumab.aspx.
38. GHSI Ministerial Statement 2002, London. March, Retrieved on March 20, 2014 from:. http://ghsi.ca/english/statementlondonmar2002.asp.
39. Goldacre Ben Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients 2012, Fourth Estate, London.
40. Healy David Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression 2004, New York UP, New York.
41. Healy David The Antidepressant Era 1997, Harvard UP, Cambridge.
42. HHS Project BioShield Annual Report to Congress January 2011-December 2011 2012, United States Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response.
43. Hoyt Kendall Medical countermeasures and security. Handbook on Global Health Security 2014, Routledge, Oxford. S. Rushton, J. Youde (Eds.).
44. Hoyt Kendall Long Shot: Vaccines for National Defense 2012, Harvard UP, Cambridge.
45. IOM Medical Countermeasure Dispensing: Emergency Use Authorization and the Postal Model 2010, Workshop Summary, Institute of Medicine.
46. Johnson Niall, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bulletin of the History of Medicine 2002, 76(1):105-115.
47. Kilbourne E.D. Influenza pandemics of the 20th century. Emerging Infectious Diseases 2006, 12(1):9-14.
48. King N.B. The influence of anxiety: September 11, bioterrorism, and American public health. Journal of the History of Medicine and Allied Sciences 2003, 58(4):433-441.
49. King N.B. Security, disease, commerce ideologies of postcolonial global health. Social Studies of Science 2002, 32(5-6):763-789.
50. Kittelsen Sonja The EU and the Securitization of Pandemic Influenza 2013, Doctoral thesis, Aberystwyth University.
51. Klotz Lynn Response to Epstein's commentary. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2008, 6(1):108-113.
52. Krasner Stephen Structural causes and regime consequences: regimes as intervening variables. International Regimes 1983, Cornell UP, Ithaca, NY. S.D. Krasner (Ed.).
53. Lakoff Andrew, Collier S.J. Biosecurity Interventions: Global Health and Security in Question 2008, Columbia UP, New York.
54. Livre Blanc Le Livre blanc sur la défense et la sécurité nationale 2013, Direction de linformation légale et administrative, Paris.
55. McInnes Colin, Lee Kelley Health, security and foreign policy. Review of International Studies 2006, 32(1):5-23.
56. McInnes Colin, Rushton Simon HIV/AIDS and securitization theory. European Journal of International Relations 2013, 19(1):115-138.
57. MOD CBR Medical Countermeasures, Defense Technology Plan 2010, Retrieved March 13, 2013 from:. http://www.science.mod.uk/strategy/dtplan/sector_istar.aspx?ThemeId=7d48c1fb-bfd3-4371-83c4-79bf094793aa%26ThemeType=rdo%26.
58. Mounier-Jack Sandra, Coker R. How prepared is Europe for pandemic influenza? Analysis of national plans. The Lancet 2006, 367:1405-1411.
59. Mounier-Jack Sandra, Jas Ria, Coker R. Progress and shortcomings in European national strategic plans for pandemic influenza. Bulletin of the World Health Organization 2007, 85.
60. NIC The Global Infectious Disease Threat and Its Implications for the US 2000, Retrieved March 20, 2014 from:. http://www.fas.org/irp/threat/nie99-17d.htm.
61. Nicoll Angus, Sprenger M. Learning lessons from the 2009 pandemic: putting infections in their proper place. European Journal of Epidemiology 2011, 26(3):191-194.
62. NSS The National Security Strategy of the United States 2006, The White House, Washington, D.C.
63. Peek Sandra The Distribution of Tamiflu Is Open to Widespread abuse 2009, Letter. The Telegraph. 29 July, Retrieved July 8, 2010 from:. http://www.telegraph.co.uk/comment/letters/5926603/The-distribution-of-Tamiflu-is-open-to-widespread-abuse.html.
64. Permanand Govin EU Pharmaceutical Regulation: The Politics of Policy-Making 2006, Manchester UP, Manchester.
65. PHE 2012 HHS PHEMCE Strategy and Implementation Plan 2012, Retrieved March 13, 2013 from:. http://www.phe.gov/Preparedness/mcm/phemce/Pages/strategy.aspx.
66. Piester Todd Strategic National Stockpile: Pandemic Influenza Countemeasures 2008, Presentation, Centers for Disease Control and Prevention, 21 August.
67. Prior Stephen Who You Gonna Call? Responding to a Medical Emergency with the Strategic National Stockpile 2004, Report Commissioned by the National Defense University, Center for Technology and National Security Policy, June.
68. Reddy David Responding to pandemic H1N1 2009 influenza: the role of oseltamivir. Journal of Antimicrobial Chemotherapy 2010, 65(Suppl.2):35-40.
69. Routledge Handbook of Global Health Security 2014, Routledge, Oxford. S. Rushton, J. Youde (Eds.).
70. Schneidmiller Chris Q&A: bioshield program successful after "rocky start," HHS preparedness chief says. Global Security Newswire 2013, Retrieved June 28, 2013 from:. http://www.nti.org/gsn/article/q-bioshield-program-successful-after-rocky-start-hhs-preparedness-chief-says/.
71. Trakatellis Antonio Pandemic Influenza in the EU: Are We Sufficiently Prepared 2007, A High Level Policy Debate Report, European Parliament, Brussels, 12 June.
72. Weir L., Mykhalovskiy E. Global Public Health Vigilance: Creating a World on Alert 2010, Routledge, London.
73. WHA Global Health Security - Epidemic Alert and Response 2001, Report by the Secretariat Prepared for the Fifty-fourth World Health Assembly. A54/9, World Health Assembly, Geneva.
74. White House The National Security Strategy of the United States of America 2002, September.
75. WHO ASafer Future: Global Public Health Security in the 21st Century: The World Health Report 2007 2007, World Health Organization, Geneva.
76. Williams S.J., Martin P.A., Gabe J. The pharmaceuticalisation of society? an analytical framework. Sociology of Health & Illness 2011, 33(5):710-725.
77. Williams Simon, Gabe J., Davis P. Pharmaceuticals and Society: Critical Discourses and Debates 2009, Wiley-Blackwell, Oxford.
78. Wright Susan Terrorists and biological weapons: forging the linkage in the clinton administration. Politics and the Life Sciences 2006, 25(1-2):57-115.